Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe.

Saved in:
Bibliographic Details
Title: Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe.
Authors: Meyer BK; Merck & Co., Inc., West Point, PA, USA., Nahas D; Merck & Co., Inc., West Point, PA, USA., An M; Merck & Co., Inc., West Point, PA, USA., Danziger A; Merck & Co., Inc., West Point, PA, USA., Smith J; Merck & Co., Inc., West Point, PA, USA., Patel M; Merck & Co., Inc., West Point, PA, USA., Lin SA; Merck & Co., Inc., West Point, PA, USA., Gleason A; Merck & Co., Inc., West Point, PA, USA., Cox K; Merck & Co., Inc., West Point, PA, USA., Capen R; Merck & Co., Inc., West Point, PA, USA., Howe J; Merck & Co., Inc., West Point, PA, USA., Bett A; Merck & Co., Inc., West Point, PA, USA.
Source: Vaccine: X [Vaccine X] 2023 Dec 09; Vol. 16, pp. 100420. Date of Electronic Publication: 2023 Dec 09 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1362 (Electronic) Linking ISSN: 25901362 NLM ISO Abbreviation: Vaccine X Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first